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Abstract
Objective: To estimate a safe minimum hospital volume for hospitals performing
coronary artery bypass graft (CABG) surgery.
Data source: Hospital data on all publicly funded CABG in five European countries,
2007-2009 (106,149 patients).
Design: Hierarchical logistic regression models to estimate the relationship between
hospital volume and mortality, allowing for case-mix. Segmented regression analysis
to estimate a threshold.
Findings: The 30-day in-hospital mortality rate was 3.0% overall, 5.2% (95% CI 4.0-
6.4) in low volume hospitals and 2.1% (95% CI 1.8-2.3) in high volume hospitals.
There is a significant curvilinear relationship between volume and mortality, flatter
above 415 cases per hospital per year.
Conclusions: There is a clear relationship between hospital CABG volume and
mortality in Europe, implying a ‘safe’ threshold volume of 415 cases per year.
3Introduction
The association between hospital volume and mortality after coronary artery bypass
graft (CABG) surgery has been explored within countries since the 1970s, when a
negative association was first described (Luft, Bunker & Enthoven 1979). A
statistically significant and clinically relevant relationship between hospital volume
and mortality has subsequently been found for many different forms of complex
surgery in both cardiac and non-cardiac specialties. Relationships are generally
attenuated but not eliminated after detailed adjustment for case-mix (Sowden, Deeks
& Sheldon 1995, Halm, Lee & Chassin 2002, Shahian 2004).
This evidence, mostly from US studies, has generated debate about ‘safe’ hospital
volumes of surgery. The ‘Leapfrog Group’, a US consortium of health care
purchasers, recommended an annual minimum hospital volume of 450 CABG cases
(Leapfrog Group 2008, Finks, Osborne and Birkmeyer 2011). Others suggest this is
too high (Shahian and Normand 2003) and that 125-150 procedures a year can be
sufficient (Shahian 2004, ACCF/AHA 2011), reflecting recent evidence that
mandatory public reporting of CABG mortality has reduced or even eliminated the
volume-outcome relationship in the USA (Marcin et al 2008). There is little evidence
of this in other countries, many of which do not have mandatory public reporting of
CABG mortality.
Some European countries – including England, The Netherlands and Sweden – have
responded to evidence of a volume-mortality relationship by centralising CABG
facilities (Banta & Bos 1991), but elsewhere hospital volumes remain low. This
difference may help to explain observed cross country differences in mortality after
cardiac surgery within Europe (Bridgewater et al 2010, Gutacker et al. 2015b). There
remains uncertainty around a minimum ‘safe’ hospital CABG volume to inform policy
4decisions in Europe and elsewhere about whether, and if so how far, to centralise
CABG services.
We use comprehensive data on CABG in five countries to describe the relationship
between hospital volume and short-term mortality, and to estimate a ‘safe’ minimum
hospital volume.
Data and Methods
Study population
The population was drawn from the European Collaboration for Healthcare
Optimisation (ECHO) project, including comprehensive record-level patient data on
all patients treated in public hospitals from a number of European countries (Bernal-
Delgado et al 2015). This study uses data from Denmark, England, Portugal,
Slovenia and Spain, 2007 to 2009. We followed the US AHRQ indicator IQI#12
(AHRQ 2015), which includes all patients who have a CABG procedure. This is
comparable with existing guidelines of ‘safe’ volume (e.g. Leapfrog Group 2008)
which apply to all procedures, not to isolated CABG. Concomitant procedures are
included in the risk-adjustment model. As a sensitivity analysis we included only
patients with isolated CABG.
Patients were excluded if they were younger than 40 or had missing information for
any of the variables used for casemix-adjustment (n=21). Hospital years were
excluded if they included less than 50 patients (< 1% of the sample).
Case-mix adjustment
5Expected deaths were predicted accounting for age group (40-55, 56-60, 61-65, 66-
70, 71-75, 76-80 and >81), sex, age-sex interactions, year of hospitalisation and
indicators for 31 Elixhauser co-morbid conditions (Elixhauser et al 1998, Quan et al
2005, Gutacker et al. 2015a). Mean number of comorbidities coded at each hospital
was included to account for possible differences in coding intensity. Models included
those measures of severity of the underlying condition, that are available in
administrative data (Higgins et al. 1992, Pagano & Gale 2014): primary diagnosis of
acute myocardial infarction (AMI), classified as ST-segment elevation (STEMI), non-
STEMI or unclear, replacement of a heart valve, implantation of a cardiac or
circulatory assistance device, and whether the intervention was major structural
surgery. We did not include emergency admission as an explanatory variable
because of differences in clinical pathways for similar patients across countries, and
because it is highly collinear with a primary diagnosis of AMI.
Clinical outcomes
The clinical outcome was in-hospital 30-day all-cause mortality. Patients who were
discharged or still in hospital 30 days after admission were classed as survivors.
Volume thresholds
We use two thresholds for overall hospital case volume derived from literature: low
(<125 cases per year) (ACCF 2011), medium (125-449 cases per year) and high
FDVHVSHU\HDU/HDSIURJ*URXS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countries we estimated statistically the threshold where the relationship between
volume of cases and outcome changed.
Statistical analysis
6Expected deaths were predicted using hierarchical logit models accounting for case-
mix. Three approaches were used to identify a volume-outcome relationship. First, a
smoothed (locally weighted) regression line was fitted through the points and
confidence intervals calculated. Second, thresholds for overall hospital case volume
derived from literature were used to compare average adjusted mortality rates for
different hospitals. Third, using pooled data a threshold was determined where the
relationship between volume and outcome appeared to change, using segmented
regression analysis. All analyses were carried out using Stata version 12.
Sensitivity analysis
We conducted four sensitivity analyses. Firstly, we restricted the population to
patients with no other surgical procedure (isolated CABG). Next, we excluded
patients who were transferred out of the hospital where the surgery took place to
another hospital as this may underestimate mortality rates. This was most
pronounced in Denmark, where around 48% were transferred for rehabilitation,
compared with 0-6.5% in the other countries. Our analyses provide two bounds of
likely mortality rates – including transfers out gives the lowest possible estimate,
assuming all who are transferred out survive. As deaths are likely to occur in the first
(specialist) hospital, excluding transfers out may over-estimate mortality rates. Third,
to mitigate between-country data differences (e.g. coding secondary diagnoses), we
re-estimated adjusting only for age, sex and year, with and without transfers. Finally,
we estimate a threshold using data from Spain and England only, which as the
largest healthcare systems in our analysis constitute the majority of observations.
Results
7106,149 patients were included in the baseline analysis, with an overall mortality rate
of 3.0%. The mean age and proportion male was similar across the countries. The
main difference in patient characteristics (Table 1) was the recorded number of co-
morbidities, notably lower in Denmark. Proportions of patients also varied by AMI
type and in overall patients who were diagnosed with AMI, from 5.6% in England to
11.6% in Spain. There was substantial variation in the volume of cases across the
five countries (Table 2).
[Table 1 about here]
[Table 2 about here]
Figure 1 illustrates CABG volume in each country and unadjusted mortality rates (see
Appendix Figure A1, for individual countries). Hospital volume was lowest and
unadjusted mortality rates highest in Spain. The case-mix adjusted relationship
between volume and outcome is illustrated in Figure 2 (left panel), showing a clear
downward curvilinear relationship. (See Appendix for effects of case-mix covariates
on outcome). Volume explains almost half of the variation in adjusted mortality rates
(R2= 0.43). Figure 2 (middle panel) illustrates the volume thresholds suggested by
US literature. The average adjusted mortality rate in lower volume hospitals was
5.2% (95% CI 4.0-6.4), falling to 1.9% (1.7-2.2) in higher volume hospitals, or 2.1%
(1.8-2.3) after weighting for hospital size (Table 3).
[Figure 1 about here]
[Figure 2 about here]
[Table 3 about here]
The centre-volume threshold that best separated hospitals where volume affects
mortality rates negatively from those were no volume effects are apparent was
8estimated at 415 procedures per hospital per year (Figure 2, right panel). Mortality
rates declined by -1.1 percentage points (95% CI -1.7 to -0.4) per 100 additional
operations below this threshold and were not affected by volume above the threshold
(-0.05 percentage points per 100 operations; 95% CI -0.16 to 0.06).
Sensitivity analyses
Sensitivity analyses did not alter the main finding of a relationship between centre
volume of cases and mortality rates (see Appendix Figures A2-A6). The threshold
centre-volume inferred by the data under the different assumptions (excluding other
procedures and transfers and simplifying risk-adjustment) did differ, ranging between
291 and 519 procedures per year. Analysis based on Spanish and English data only
(Figure A7) suggested a threshold of 512 procedures per year.
Discussion
We found substantial differences in short-term mortality following CABG surgery in
hospitals across five European countries. Patients treated in lower volume hospitals
had significantly higher 30-day in-patient mortality rates. Below 415 cases per
hospital per year, mortality rates increased at a greater rate. Between-country
variations in volume are clearly associated with international differences in mortality
rates, of which hospital volume explains a large proportion after adjustment for case-
mix.
Our findings are consistent with earlier studies, primarily from the USA. More recent
US studies have however focused on the importance of public reporting of CABG
surgery performance, which appears to have attenuated the volume-outcome effect.
For example, Marcin et al (2008), found a small but consistent volume-outcome
9relationship during a time when public reporting was voluntary, but that this
disappeared once reporting was mandated.
A relationship between volume and outcome could be the result of hospital-level
processes, individual surgeon experience (Birkmeyer et al 2003) or both. Moreover,
hospital volume of cases may be a marker for hospital quality (Peterson et al 2004)
or possibly a more direct determinant of mortality. Our study includes five different
European healthcare systems, with different levels of concentration of cardiac
surgery services, a key institutional feature influencing CABG outcomes. The mix of
organizational systems increases the external validity of the results.
Our study confirms the presence of a strong centre-volume outcome relationship
using comprehensive data on all publicly funded patients and hospitals across five
countries. Low and medium volume hospitals have substantially and statistically
significantly higher adjusted mortality than high volume hospitals. The reduction in
mortality risk of moving from “medium” to “high” volume appears greater than the
reduction from moving from the “low” to “medium” category.
The data-driven estimate of the threshold volume, 415 cases per year, is similar to
the 450 recommended by the US Leapfrog group (2008), lower than the 600
implemented by the Netherlands in the 1990s (Banta & Bos 1991) but substantially
higher than the 125-150 recommended in recent US guidelines (ACCF 2011). The
ACCF guidelines, however, reflect transparency about cardiac surgery performance,
which is not publicly available in many countries outside the US (although it is
available in the UK).
This analysis demonstrates the importance of international comparisons using
administrative data and a pooled benchmark. This research, with a related study
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(Gutacker et al 2015b), shows that restricting benchmarks to a region or even a
country may provide false reassurance if there are systematic differences between
countries. A threshold would not be adequately informed by any single country’s
data, and no one of these countries would have provided a sufficient sample to
determine a volume-outcome relationship – Spanish hospitals are all (relatively) low-
volume, English hospitals are all relatively high volume and the other three countries
have only 3–6 medium volume hospitals conducting CABG surgery.
Our findings raise important policy questions about the concentration of services,
particularly in countries with low volume hospitals, such as Spain. The Spanish
health care system is decentralised in its decision-making: hospitals are organised by
autonomous communities and districts. Political opposition to centralisation of
services may contribute to explaining the relatively low hospital volume. In contrast,
in England, networks of care, higher volume centres and transparent reporting of
hospital and surgeon mortality rates has driven quality improvements (Bridgewater et
al 2007).
There may be geographical, political or practical difficulties that prevent substantial
changes in service delivery in some communities in the short to medium term. In the
absence of immediate policies to centralise cardiac surgical provision, it is important
to consider how best to improve mortality rates in low-volume units. Our analysis
does not permit direct exploration of this, but potential quality improvement
processes include participation in registries and associated initiatives (Bridgewater et
al 2010, Shahian et al 2009) public reporting initiatives and improved transparency
(Steinbrook 2006, Grant et al. 2013), and regional partnerships and quality
improvement collaboratives (O’Connor et al 1996, Finks, Osborne and Birkmeyer
2011). Public reporting in the US appears to have reduced or even eliminated the
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previous volume-outcome relationship, and this may be more achievable than
centralisation of services in a devolved health care system like Spain.
Previous international studies in this area have relied on clinical registry data
(Bridgewater et al 2010). In most countries, however, registry data is collected
voluntarily and remains vulnerable to selection bias, if hospitals and surgeons with
low mortality rates are more likely to participate (Bufalino et al. 2011). This is the first
international study of the CABG volume-mortality relationship to use comprehensive
international comparisons of patient-level hospital administrative data. Our approach
avoids selection bias, but has a more limited set of covariates for case mix
adjustment.
Other limitations also remain. First, not all countries could provide mortality data
outside hospital for an overall 30-day mortality rate. We used in-hospital 30-day
mortality because the length of hospital stay varied across countries, making in-
patient mortality rates a less than ideal basis for comparison (Spiegelhalter 2013). If
high volume hospitals discharge patients earlier then our estimated association
between volume and outcome may be biased downwards.
Second, there may be cross-country differences in coding. CABG is well-defined and
patient characteristics and secondary diagnoses similar in four countries (Table 1),
but apparent differences in comorbidity recording in Denmark may overestimate their
adjusted mortality rates. There are also coding differences in concomitant procedures
(e.g. apparently large numbers of heart valve replacements and cardiac assistance
devices in Slovenia). Our sensitivity analyses, using only age and sex as risk-
adjustment measures to avoid any hospital or country level differences in coding, and
including isolated CABG only, do not change the main findings of the analysis (see
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Appendix). A strong and significant association between volume and outcomes
remains.
Finally, there may be hospital- or national-level differences in choice of treatments for
similar conditions, in particular the choice between CABG surgery and percutaneous
coronary interventions (PCIs) (Taggart 2009, Hlatky et al. 2009). Our dataset
suggests that England (which dominates the high-volume segment) provides more
CABG as a proportion of all revascularisation procedures than the other countries: 30
CABG procedures to 70 PCIs in England over the period compared with around
20:80 in Portugal and Denmark and 15:85 in Slovenia and Spain. This raises the
question of differential selection between CABG and PCI procedures, but in initial
explorations of PCI data in the ECHO data warehouse there was no negative
correlation between hospital-level standardised mortality rates following CABG and
PCI (R=0.045).
Overall, our findings demonstrate a strong and statistically significant relationship
between hospital volume of CABG surgery and in-hospital 30-day mortality, and a
threshold of 415 cases per hospital per year above which mortality rates are stable
and on average much lower. All hospitals in Spain were below this threshold,
whereas all hospitals in England were above it. Higher volume, higher throughput
systems of care have the potential to reduce mortality rates further and there may be
an international case to regionalise services where the hospital volume of CABG
surgery is low.
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1Table 1: Patient characteristics
Denmark
n=7,168
England
n=67,450
Portugal
n=7,639
Slovenia
n=2,345
Spain
n=21,547
Total
n=106,149
Age: mean (SD), years 67.1 (9.3) 67.4 (9.6) 66.3 (9.7) 67.6 (9.2) 67.7 (9.6) 67.4 (9.6)
Male (%) 79.2 78.8 76.5 74.1 78.1 78.4
Number of co-morbidities: mean (SD) 1.0 (1.2) 2.0 (1.4) 1.9 (1.4) 2.0 (1.4) 2.2 (1.4) 2.0 (1.4)
No co-morbidities (%) 44.5 12.7 16.3 12.1 10.0 14.6
1 co-morbidity (%) 27.0 27.9 28.1 29.9 24.0 27.5
2-3 co-morbidities (%) 24.1 45.5 43.4 45.2 49.7 44.8
4+ co-morbidities (%) 4.4 13.9 12.2 13.9 16.3 13.6
ST-elevation myocardial infarction (%) 0.8 1.8 2.9 3.5 4.6 2.4
Non ST-elevation myocardial infarction (%) 3.4 0.5 6.0 5.5 6.3 2.4
Unspecified myocardial infarction (%) 1.9 2.4 0.1 0.4 0.7 1.8
Heart valve surgery (%) 29.5 7.5 4.0 83.0 5.9 10.1
Cardiac assistance device surgery* (%) 3.3 9.2 4.2 42.4 3.9 8.1
Repair/revision or major structural surgery (%) 19.9 18.6 20.8 30.1 27.1 20.8
*includes cardiac pacemaker and automatic implantable cardioverter defibrillator insertion during the same hospital stay
2Table 2: Descriptive statistics
Denmark England Portugal Slovenia Spain Total
Number of hospital years* 18 87 18 9 129 261
Total volume (2007-2009)* 7,168 67,450 7,639 2,345 21,547 106,149
Mean (median) volume per hospital per year 398 (410) 775 (709) 424 (429) 260 (205) 167 (152) 407 (279)
Minimum – maximum volume per hospital per year 239-544 466-1372 238-537 95-480 68-318 68-1372
Mean (SD) length of stay, days ** 14.3 (8.4) 11.6 (7.2) 11.6 (6.8) 15.5 (8.6) 17.0 (8.3) 13.0 (7.8)
Transfers out, % 47.9 6.5 0.0 4.9 2.6 8.0
Mean (SD) 30-day in-hospital mortality rate %, including transfers** 2.8 (16.6) 2.2 (14.5) 2.3 (15.0) 3.5 (18.4) 4.9 (21.5) 3.0 (16.5)
Mean (SD) mortality rate % excluding transfers (sensitivity analysis)** 5.1 (22.1) 2.3 (15.0) 2.3 (15.0) 3.7 (18.8) 5.0 (21.8) 3.0 (17.1)
* hospital years with less than 50 patients were excluded
**mortality and length of stay are truncated at 30 days
1Table 3: Adjusted 30-day in-hospital mortality rates in low, medium and high volume
hospitals
Volume (cases per
hospital per year)
No. of
hospitals
Adjusted mortality
rates, mean (95% CI),
unweighted
Adjusted mortality
rates, mean (95% CI),
weighted by hospital
volume
Low (<125) 15 5.2% (4.0 to 6.4) 5.1% (3.9 to 6.3)
Medium (125-449) 37 4.4% (3.6 to 5.1) 4.1% (3.3 to 4.8)
+LJK  WR 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
2Figure 1: Unadjusted 30-day in-hospital 30-day mortality rates and hospital annual
volume by country
1Figure 2: Adjusted 30-day in-hospital mortality rate and hospital annual volume, all five countries pooled. LOWESS plot (left panel), average
mortality by volume group (middle panel), segmented regression line (right panel). Estimated threshold volume: 415 procedures per hospital
per year
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